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ABSTRACT
Multiple technologies that measure expression levels of 
protein mixtures in the human body offer a potential for 
detection and understanding the disease. The recent in-
crease of these technologies prompts researchers to 
evaluate the individual and combined utility of data 
generated by the technologies. In this work, we study 
two data sources to measure the expression of protein
mixtures in the human body: whole-sample MS profil-
ing and multiplexed protein arrays. We investigate the 
individual and combined utility of these technologies by 
learning and testing a variety of classification models
on the data from a pancreatic cancer study. We show 
that for the combination of these two (heterogeneous)
datasets, classification models that work well on one of
them individually fail on the combination of the two da-
tasets.  We study and propose a class of model fusion 
methods that acknowledge the differences and try to 
reap most of the benefits from their combination.
INTRODUCTION
Multiple novel technologies that measure expression 
levels of complex protein mixtures in the human body 
from a variety of specimen, such as blood or urine, of-
fer a great potential for improved detection and under-
standing of the disease. With the recent increase in the 
number of these technologies the challenge becomes 
the understanding of individual and combined benefits 
of data generated by these technologies.  As the possi-
bilities increase, so does the data production and re-
searchers are pressed to find the best methods suitable 
for their combined analysis. In this work we study two 
such technologies: [1] multiplexed protein arrays, and 
[2] MS spectrometry proteomic profiling, and analyze 
their individual and combined benefits in context of 
disease detection. 
Luminex arrays. Conventional assay methodologies, 
such as ELISA, RIA, or PCR permit the analysis of a 
single, or a limited number of markers.   Assay tech-
niques that can simultaneously examine a large number 
of pre-selected proteomic biomarkers from a small 
amount of serum are hence of great potential value for 
better characterization of the disease.  Luminex Corpo-
ration (http://www.luminexcorp.com) has recently in-
troduced a novel protein array system, xMAP®, 
which allows for simultaneous assessment and 
quantitation of up to 100 soluble analytes in one 
sample. These analytes are carefully picked and in-
clude immunogenic and growth factor markers such 
as:  IL-2, IL 8, MMP-7, MMP-12, IP-10 and others. 
Time-of-flight mass spectrometry (TOF-MS) has 
become a widely used tool for the rapid analysis of 
protein-mass content in a variety of biospecimen 
(blood, urine, cell-lysates).  Thousands of mass 
measurements of molecules present in the sample 
appear along the profile. Despite the overlap in mass 
signatures of these species, it is possible to find dis-
criminatory patterns which distinguish the profiles 
of diseased and healthy patients. The technology has 
been used to successfully find patterns and predic-
tive models for several diseases, including cancer [1,
2, 3, 4], arthritis [5], ALS [6] etc. 
Disease detection. Classification learning methods 
allow us to extract models that permit detection of a 
disease from data. Unfortunately, a single machine 
learning model or a method that fits all possible da-
tasets and consistently gives the best possible per-
formance does not exist. We investigate the individ-
ual and combined potential of data generated by 
these two technologies on detecting disease in pa-
tients with pancreatic cancer by learning and testing 
a variety of classification models.  The samples are 
based on the study conducted at the University of 
Pittsburgh Cancer Institute and data used in [7]. 
Challenges. Luminex and SELDI-TOF-MS tech-
nologies provide data that may indicate through va-
riety of patterns the presence or absence of the dis-
ease. However, the differences in the nature of data 
generated by them raise concerns that they are not 
easy to combine into a single machine learning 
model. First, the immunogenic and growth factor 
proteomic markers measured by Luminex xMAP®
technology are likely to be biologically independent 
of SELDI-TOF-MS profile features and patterns, 
thus providing complementary information about 
the disease. Second,  SELDI-TOF-MS data are high 
dimensional and typically involve hundreds of mea-
surements, while Luminex arrays are restricted to at 
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most 100 probes (typically 30-60 probes) of pre-
selected species.  Third, MS-data tend to exhibit a large 
amount of signal correlates, while Luminex is a collec-
tion of independent probes with fewer correlations. 
We show that features of the two data sources can be 
successfully captured by two different machine learning 
models. Second, we show and that a naïve combination 
of the data from both data sources does not lead to im-
provements in any of the two models and in one in-
stance the results are much worse. To reap the benefits 
of the combination of the data-sources we propose and 
study machine learning models that acknowledge the 
differences in the two data streams and demonstrate 
their combined classification improvement.   
DATA 
The pancreatic dataset used in this study consists of 
106 samples, with 56 cases and 53 smoking- age and 
gender matched controls collected at the University 
of Pittsburgh Cancer Institute. There are two differ-
ent data sources for these samples: 1554 peaks from 
SELDI-TOF-MS profiles and 30 measurements from 
Luminex data.
Luminex array data. Luminex Corporation’s xMAP®
technology uses polystyrene microspheres internally 
dyed with two spectrally distinct fluorophores to create 
a family of 100 spectrally addressed bead sets. Each 
bead set can be conjugated with a capture antibody spe-
cific for a unique target protein. In a multiplexed assay, 
antibody-conjugated beads are allowed to react with 
sample (plasma, serum or cell culture supernatant). Af-
ter washing, secondary phycoerythrin (PE) conjugated 
antibodies are added to to form a capture sandwich im-
munoassay.  The assay solution was analyzed by the 
array Bio-Plex reader from Bio-Rad, which obtains two 
readings for every single bead: one that identifies a flu-
orochrome labeled bead, and another that measures the 
amount of PE fluorescence of the PE-conjugated detec-
tion antibody associated with the bead. The amount of 
PE fluorescence is proportional to the amount of ana-
lyte captured in the immunoassay. Bio-Plex Manager 
software (Bio-Rad) correlates each bead set to the assay 
reagent that has been coupled to it and estimates the 
concentration of each analyte in the sample. Using the 
assay, thousands of beads can be analyzed in seconds, 
allowing up to 100 analytes to be measured in a 96-well 
microplate in one hour.
MS proteomic profiles Mass spectrometry proteomic 
profiling of serum samples was performed using SEL-
DI-TOF-MS profiling technology (Ciphergen Biosys-
tems, Inc.) The samples from the study were analyzed 
are spotted in duplicate on the IMAC-3 ProteinChip® 
array in blinded combined case/control batches.  
The protocols for the preparation and loading of se-
rum samples for SELDI-TOF-MS analysis are spe-
cific for the ProteinChipr Arrays (Ciphergen Biosys-
tems, Inc.). Fully automated BioMek2000r protocols 
for processing of IMAC3 ProteinChipr Arrays are 
presently being utilized in the UPCI Clinical Pro-
teomics Facility. Protocols for automated processing 
of these ProteinChipr Arrays, as well as performing 
mass spectrometry and preprocessing of the spectral 
data for analysis, have been derived and optimized 
from protocols implemented and validated in this 
facility.  
To eliminate systematic biases and noise in the MS 
data we apply five preprocessing steps implemented 
in the Proteomic data analysis package (PDAP)
[7]: (1) variance stabilization, (2) baseline correc-
tion, (3) smoothing, (4) intensity normalization, and 
(5) profile alignment steps.  Briefly, from many 
choices offered and implemented by PDAP we ap-
plied the following preprocessing choices: cube-root 
variance stabilization, PDAP’s baseline subtraction
routine based on the local moving window of width 
200 time-points, Gaussian-kernel smoothing, peak-
based dynamic programming alignment and the total 
ion current normalization restricted to the range of 
1500-20000 Daltons. The qualities of profiles were 
tested beforehand on raw MS profile readings. None 
of the profiles used exhibited total ion current (TIC) 
that differed by more than two standard deviations 
from the mean TIC, which is our quality-assurance
/quality-control threshold for sample exclusion.  
Peak selection. The majority of proteomic data ana-
lyses in literature restrict their attention only to in-
formation represented in the peaks of the signal.  
Our peak selection procedure works with the mean 
profile obtained by averaging all profiles the train-
ing data. The approach is robust enough even if a 
specific peak is not recorded in all profiles, whilst it 
tends to average out random signal fluctuations. The 
peak locations are identified by calculating the sig-
nal derivatives.  The peak intensities are average of 
readings in a local neighborhood of the peak loca-
tion.  Such a method reduces the chance of a noisy 
reading at a single m/z position.
METHODS OF ANALYSIS
Our aim is to build a classification model  
Yf →X:  that can, with a high accuracy, assign 
correct class labels Y (case or control) to profiles
(X) collected for patients in the study.  We adopt a 
machine learning approach in which the model is 
learned and evaluated from the data in the study.  
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A number of different models and algorithms built for 
the classification learning task exist.  The methods in-
clude:  linear discriminant analysis, CART, support vec-
tor machines, logistic regression, Naïve Bayes and oth-
ers.  However, many of these off-shelve classification 
models are not immediately applicable to analysis of 
high dimensional proteomic datasets. The main reason is 
a small sample size of studies combined with the dimen-
sionality of the data. This lead to a model overfit where 
every sample in the dataset is fit via one or more pa-
rameters which in turn affects model’s generalization 
performance. To address the problem our investigations 
have primarily focused on two classification models with 
robust generalization performances on both lower and 
high dimensional data: Support vector machines (SVMs) 
and Random Forests. These methods are currently avail-
able in our PDAP package [7]. 
The linear support vector machine or SVM [8, 9] 
learns a linear decision boundary that separates the n-
dimensional feature space into 2 partitions. The bound-
ary is a hyperplane given by the equation
00 =+ w
T xw , where w is the normal to the hyper-
plane, and 0w  is the distance separating the “support 
vectors” - representative samples from each class which 
are most helpful for defining the decision boundary. The 
parameters of the model, w and 0w , can be learned from 
data through quadratic optimization using a set of La-
grange parameters iαˆ . These parameters allow us to 
redefine the decision boundary as 
where only samples in the support vector contribute to 
the computation of the decision boundary.  The support 
vector machine comes with built in regularization abili-
ties which perform very well when high dimensional 
datasets needs to be analyzed. [8, 17]
Random forest [11] is an ensemble classifier [12] that 
combines the results of multiple decision trees classifi-
ers through averaging. The decision trees in the ensem-
ble are built using Classification and Regression Tree 
(CART) [13] or other tree-building algorithms, but the 
tree building is enriched through random feature selec-
tion process. Decision trees tend to work well for lower 
dimensional data and their advantage is the ability to 
capture various differences in between the groups via 
multiple non-linear decision splits. Random feature se-
lection lets us to consider subsets of features rather than 
all features when learning the decision classifier which
is believed to be an advantage if the dimensionality of 
the data is large when compared to the number of sam-
ples.
Combination of data sources
The simplest method to combine data from multiple 
data sources for classification purposes is to merge
them together. A classifier is build for all data at 
once. The advantage of the approach is that no new 
models need to be considered, the limitation is that 
the performances of classifiers one can achieve on 
data corresponding to individual data sources may 
become hard to improve. 
There is no universal classifier that works the best 
for all possible data sources. [16] Instead one often 
sees one classifier dominating the other on certain 
type of data. [16] Hence it is possible that different 
(base) classifiers exhibit the dominance for the data 
sources we have. The key challenge is to develop 
classification models that let us fit individual data 
sources well and after that combine their perform-
ance to improve the overall classification accuracy. 
To address this problem we investigate two methods 
for combining different classification models: (1) 
model inclusion and (2) model composition.  Both 
of these models take advantage of an opportunity to 
build soft discriminative projections from existing 
classification models. For SVM, it is a distance from 
a hyperplane ( 00 =+ wT xw ). Likewise, in RF, we 
can compute the ratio of the trees that favor a par-
ticular class. We use these soft discriminative func-
tions to design a compound classifier for the com-
bined data sources.
Model inclusion: First, we can use a soft output 
from one classifier as an extra feature for another. 
For example: We take SELDI data and learn a SVM 
for it. Then we the (train) data projected on a hyper-
plane and include this (1 dimensional) vector as an 
extra feature with the Luminex data. Eventually, we 
learn a RF classifier for the merged data.  Con-
versely we can take tree ratio from the Luminex data 
and add it as and extra feature with SELDI for 
SVM.
Model composition approach builds a two layer 
classification model. On the first level a base classi-
fier for a given data type is learned and its  (soft) 
discriminative output is used as an input for a new 
(second level) classifier.  For example, by doing this 
we can combine a distance from the hyperplane 
(from SVM) and tree ratio (from RF) to train a new 
classifier. 
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Evaluation of the classification model quality
The quality of each model using random re-sampling 
validation schemes [14]. Briefly, our goal is to evaluate 
the generalization performance of the model, that is, its 
performance on samples we expect to see in the future. 
Since these are not available we split the data available 
to us into the training and test set. The model is always 
learned on the training set and tested on the test set.  
We use random sub-sampling approach to divide the 
dataset using 70/30 train/test split. To avoid potential 
biases due to a single train/test split we repeat the anal-
ysis on multiple (40) random splits and average their 
results. Each classification model is evaluated using: 
the accuracy, sensitivity and specificity of the model 
under 0-1 loss function and the Area under the ROC 
curve. 
RESULTS AND DISCUSSION 
Table 1 displays classification error (ACE), sensitivity, 
specificity statistics obtained by the SVM, CART, NB 
and RF models on MS proteomic data and the Luminex 
data both individually and after they are (data) merged.
The first three statistics are obtained under the 0-1 clas-
sification loss model. Figure 1 and Figure 2 show 
ROC curves, their AUC statistics for the RF and SVM 
models. All reported statistics are averages over 40 in-
dependent train/test splits of the entire dataset.
The results show that if the data are taken individually 
the RF model performs better on the Luminex data, 
while SVM is better on MS data. The fact that these 
two models perform differently can be explained by the 
differences in the measurements these data-sources rep-
resent. The MS data are high dimensional and involve a 
rather high number of correlated signals. On the other 
hand, the Luminex data are lower dimensional and rep-
resent independent probes and their measurements are 
less correlated.  If the data are taken together both mod-
els lose their performance. The RF appears to be over-
whelmed by the dimensionality of the SELDI data, 
while linear SVM is limited to linear decision boundary 
which does not appear to capture well discriminative 
signals in Luminex data. All these results demonstrate 
the difficulties arising from the straightforward combi-
nation of the two data sources.
Error SN SP
CART 25.66% 63.31% 89.47%
std 18.90% 31.93% 22.68%
NB 23.09% 60.52% 94.33%
std 12.07% 22.30% 6.14%
LogisticR 21.76% 75.94% 80.74%
std 5.64% 10.99% 10.95%
RF 9.41% 91.93% 89.89%
std 4.77% 6.56% 8.79%
SVM 23.97% 72.11% 80.08%
LU
M
IN
EX
std 7.37% 11.33% 10.08%
CART 36.99%  59.49% 68.32%
std '8.32% 17.44% 20.28%
NB 45.29% 83.71%  25.24%
std '8.73% 8.18% 12.95%
LogisticR  36.69% 63.56% 63.48%
std 8.48% 15.10% 10.88%
RF 32.35% 70.32% 67.23%
std 9.18% 14.37% 16.45%
SVM 16.62% 83.04% 84.71%SE
LD
I P
EA
K
S
std 7.37% 10.88% 9.77%
CART 22.94% 68.00% 88.87%
std 16.07% 25.71% 22.71%
NB 44.63% 74.21% 37.74%
std 9.97% 26.28% 25.40%
LogisticR 38.38% 60.72% 62.56%
std 9.30% 12.51% 12.11%
RF
 21.54% 76.58% 82.37%
std 7.98% 13.67% 13.22%
SVM 34.49% 50.82% 79.83%SE
LD
I P
EA
K
S
+
 
LU
M
IN
EX
std 12.12% 36.76% 22.42%
Table 1: Data Fusion
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Figure 1: ROC for linear SVM
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luminex :: RF     
AUC: 0.98 sd: 0.02
seldi peaks + luminex :: RF 
AUC: 0.88 sd: 0.06          
seldi peak :: RF  
AUC: 0.78 sd: 0.06
Figure 2: ROC for Random Forest
Table 2 compares different model-combination so-
lutions proposed for the data combination problem. 
The model composition approach is implemented 
with the Naïve Bayes model as a second level classi-
fier. For comparison sake we have included also the 
result for the RF classifier that was trained on Lu-
minex data and top 50 differential features identified 
in the SELDI-TOF-MS data. The differential feature 
selection was based on the t-test scoring. Although, 
the difference between those ROC curves is not sta-
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tistically significant, each one of them is significantly 
better than the best ROC for the data fusion. For exam-
ple, Figure 3. compares the ROCs for the best data 
fusion and the best model fusion scenario. The ROC for 
the model fusion model is significantly better (p < 
0.0086) than the one for the Random Forest on merged 
data. For the significance analysis, we used variance 
corrected resampled paired t-test [15]. 
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seldi peaks + luminex :: 
RF - AUC: 0.88 sd: 0.06  
SVM(seldi peaks) + RF(luminex) :: 
NB - AUC: 0.98 sd: 0.02           
Figure 3: Comparison of the ROC curves for the best data
fusion and the best model fusion model
Error SN SP
NB 8.82%  91.28% 91.60%SVM(seldi) + RF(luminex)
std 4.42% 7.90% 7.91%
RF 9.71% '91.29%  89.88%SVM(seldi) + luminex Std 4.53% 7.22% 8.40%
SVM  8.46% 92.56% 91.03%
seldi peaks + RF(luminex) Std 3.78% 5.98% 6.58%
RF  9.85% 88.83%  92.12%T_test50(seldi) + luminex
std 4.78% 9.23% 7.24%
Table 2: Model Combination
The results in Table 2 and Figure 3 demonstrate im-
provement with the model combination approach over 
the classification when we merely merged the data. 
Compound classifiers seem to be able to merge the dis-
criminative information along with merging the data. 
However, we note that the model combination results
are only slightly better or comparable to plain luminex 
classification. This indicates that most of the discrimi-
native information is offered by the Luminex panel. 
CONCLUSION
With many new bioinformatics data-sources that will 
emerge in years to come, building of improved disease 
detection models by utilizing multiple data sources be-
comes a necessity. In this work we showed that simple 
data merge may not be the solution to the problem and 
that it may prevent us from maximizing the benefit of
information in the data. More specifically, we showed
that the data merge for two proteomic data sources and 
a fixed classification model may lead to the deteriora-
tion of classifier’s predictive performance over indi-
vidual data sources. To address the problem we stu-
died an alternative classification solution in which 
models built for different data-sources and not data 
are combined. We illustrated the benefit of the mod-
el approach on our two-source dataset. While the 
results of this initial study are hard to generalize, the 
mere existence of the problem shows that full utili-
zation of multiple data-sources in classification 
tasks may go beyond the simple data merge solution
. 
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